{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:31:17Z","timestamp":1699835477315},"posted":{"date-parts":[[2023,11,1]]},"group-title":"In Review","reference-count":36,"publisher":"Research Square Platform LLC","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,10,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n        <jats:p><jats:bold>Background:<\/jats:bold> Conventional radiation therapy for glioblastoma (GBM) has limited efficacy. Regenerative medicine brings hope for repairing damaged tissue, opening opportunities for elevating the maximum acceptable radiation dose. In this study, we explored the effect of ultra-high dose fractionated radiation on brain injury and tumor responses in immunocompetent mice. We also evaluated the role of the HIF-1\u03b1 under radiation.\n<jats:bold>Methods<\/jats:bold>: Na\u00efve and hypoxia-inducible factor-1 alpha (HIF-1\u03b1)<jats:sup>+\/-<\/jats:sup> heterozygous mice received a fractionated daily dose of 20 Gy for three or five consecutive days. Magnetic resonance imaging (MRI) and histology were performed to assess brain injury post-radiation. The 2\u00d710<jats:sup>5<\/jats:sup> human GBM1 luciferase-expressing cells were transplanted with tolerance induction protocol. Fractionated radiotherapy was performed during the exponential phase of tumor growth. BLI, MRI, and immunohistochemistry staining were performed to evaluate tumor growth dynamics and radiotherapy responses. Additionally, animal lifespan was recorded.\n<jats:bold>Results<\/jats:bold>: Fractionated radiation of 5\u00d720 Gy induced severe brain damage, starting 3 weeks after radiation. All animals from this group died within 12 weeks. In contrast, later onset and less severe brain injury were observed starting 12 weeks after radiation of 3\u00d720 Gy. It resulted in complete GBM eradication and survival of all treated animals. Furthermore, HIF-1\u03b1<jats:sup>+\/-<\/jats:sup> mice exhibited more obvious vascular damage 63 weeks after fractionated radiation of 3\u00d720 Gy.\n<jats:bold>Conclusion<\/jats:bold>: Ultra-high dose fractionated 3\u00d720 Gy radiation can eradicate the GBM cells at the cost of only mild brain injury. The HIF-1\u03b1 gene is a promising target for ameliorating vascular impairment post-radiation, encouraging the implementation of neurorestorative strategies.<\/jats:p>","DOI":"10.21203\/rs.3.rs-3500563\/v1","type":"posted-content","created":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T19:18:31Z","timestamp":1698866311000},"source":"Crossref","is-referenced-by-count":0,"title":["Unlocking the potential of ultra-high dose fractionated radiation for effective treatment of glioblastoma"],"prefix":"10.21203","author":[{"given":"Xiao-Yan","family":"Lan","sequence":"first","affiliation":[{"name":"Dalian Municipal Central Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukasz","family":"Kalkowski","sequence":"additional","affiliation":[{"name":"University of Maryland Baltimore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Yan","family":"Chu","sequence":"additional","affiliation":[{"name":"University of Maryland Baltimore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Jablonska","sequence":"additional","affiliation":[{"name":"University of Maryland Baltimore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shen","family":"Li","sequence":"additional","affiliation":[{"name":"Capital Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihoko","family":"Kai","sequence":"additional","affiliation":[{"name":"Johns Hopkins University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Gao","sequence":"additional","affiliation":[{"name":"University of Maryland Baltimore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miroslaw","family":"Janowski","sequence":"additional","affiliation":[{"name":"University of Maryland Baltimore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Walczak","sequence":"additional","affiliation":[{"name":"University of Maryland Baltimore"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8761","reference":[{"issue":"Suppl 5","key":"ref1","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noac202","article-title":"CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015\u20132019","volume":"24","author":"Ostrom QT","year":"2022","unstructured":"Ostrom QT, Price M, Neff C, et al. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015\u20132019. Neuro Oncol. 2022;24(Suppl 5):v1\u2013v95. 10.1093\/neuonc\/noac202.","journal-title":"Neuro Oncol"},{"issue":"2","key":"ref2","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/bjc.2015.421","article-title":"Has the survival of patients with glioblastoma changed over the years?","volume":"114","author":"deSouza RM","year":"2016","unstructured":"deSouza RM, Shaweis H, Han C, et al. Has the survival of patients with glioblastoma changed over the years? Br J Cancer. 2016;114(2):146\u201350. 10.1038\/bjc.2015.421.","journal-title":"Br J Cancer"},{"issue":"3","key":"ref3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1200\/jco.2016.70.7562","article-title":"Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline","volume":"35","author":"Sulman EP","year":"2017","unstructured":"Sulman EP, Ismaila N, Armstrong TS, et al. Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline. J Clin Oncol. 2017;35(3):361\u20139. 10.1200\/jco.2016.70.7562.","journal-title":"J Clin Oncol"},{"issue":"5","key":"ref4","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1053\/j.seminoncol.2004.07.013","article-title":"Cognitive sequelae of brain radiation in adults","volume":"31","author":"Laack NN","year":"2004","unstructured":"Laack NN, Brown PD. Cognitive sequelae of brain radiation in adults. Semin Oncol. 2004;31(5):702\u201313. 10.1053\/j.seminoncol.2004.07.013.","journal-title":"Semin Oncol"},{"issue":"6","key":"ref5","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1200\/jco.2002.20.6.1635","article-title":"Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy","volume":"20","author":"Chan JL","year":"2002","unstructured":"Chan JL, Lee SW, Fraass BA, et al. Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy. J Clin Oncol. 2002;20(6):1635\u201342. 10.1200\/jco.2002.20.6.1635.","journal-title":"J Clin Oncol"},{"issue":"1","key":"ref6","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1158\/1078-0432.Ccr-11-2073","article-title":"Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastoma","volume":"18","author":"Tsien CI","year":"2012","unstructured":"Tsien CI, Brown D, Normolle D, et al. Concurrent temozolomide and dose-escalated intensity-modulated radiation therapy in newly diagnosed glioblastoma. Clin Cancer Res. 2012;18(1):273\u20139. 10.1158\/1078-0432.Ccr-11-2073.","journal-title":"Clin Cancer Res"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"407026","DOI":"10.1155\/2014\/407026","article-title":"Hypofractionated high-dose irradiation with positron emission tomography data for the treatment of glioblastoma multiforme","volume":"2014","author":"Miwa K","year":"2014","unstructured":"Miwa K, Matsuo M, Ogawa S, et al. Hypofractionated high-dose irradiation with positron emission tomography data for the treatment of glioblastoma multiforme. Biomed Res Int. 2014;2014:407026. 10.1155\/2014\/407026.","journal-title":"Biomed Res Int"},{"issue":"5","key":"ref8","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.ijrobp.2021.03.032","article-title":"Initial Results of a Phase 2 Trial of (18)F-DOPA PET-Guided Dose-Escalated Radiation Therapy for Glioblastoma","volume":"110","author":"Laack NN","year":"2021","unstructured":"Laack NN, Pafundi D, Anderson SK, et al. Initial Results of a Phase 2 Trial of (18)F-DOPA PET-Guided Dose-Escalated Radiation Therapy for Glioblastoma. Int J Radiat Oncol Biol Phys. 2021;110(5):1383\u201395. 10.1016\/j.ijrobp.2021.03.032.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"ref9","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1007\/s12035-015-9628-x","article-title":"Pathophysiological Responses in Rat and Mouse Models of Radiation-Induced Brain Injury","volume":"54","author":"Yang L","year":"2017","unstructured":"Yang L, Yang J, Li G, et al. Pathophysiological Responses in Rat and Mouse Models of Radiation-Induced Brain Injury. Mol Neurobiol. 2017;54(2):1022\u201332. 10.1007\/s12035-015-9628-x.","journal-title":"Mol Neurobiol"},{"issue":"2","key":"ref10","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1093\/cvr\/cvq045","article-title":"Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling","volume":"86","author":"Rey S","year":"2010","unstructured":"Rey S, Semenza GL. Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling. Cardiovasc Res. 2010;86(2):236\u201342. 10.1093\/cvr\/cvq045.","journal-title":"Cardiovasc Res"},{"issue":"1","key":"ref11","doi-asserted-by":"publisher","first-page":"1776577","DOI":"10.1080\/2162402x.2020.1776577","article-title":"Modeling human pediatric and adult gliomas in immunocompetent mice through costimulatory blockade","volume":"9","author":"Lan X","year":"2020","unstructured":"Lan X, Kedziorek DA, Chu C, et al. Modeling human pediatric and adult gliomas in immunocompetent mice through costimulatory blockade. Oncoimmunology. 2020;9(1):1776577. 10.1080\/2162402x.2020.1776577.","journal-title":"Oncoimmunology"},{"issue":"2","key":"ref12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1134\/s0006297916020036","article-title":"Problems of Glioblastoma Multiforme Drug Resistance","volume":"81","author":"Stavrovskaya AA","year":"2016","unstructured":"Stavrovskaya AA, Shushanov SS, Rybalkina EY. Problems of Glioblastoma Multiforme Drug Resistance. Biochem (Mosc). 2016;81(2):91\u2013100. 10.1134\/s0006297916020036.","journal-title":"Biochem (Mosc)"},{"issue":"1","key":"ref13","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1227\/neu.0000000000000801","article-title":"Impact of Timing of Concurrent Chemoradiation for Newly Diagnosed Glioblastoma: A Critical Review of Current Evidence","volume":"62","author":"Han SJ","year":"2015","unstructured":"Han SJ, Englot DJ, Birk H, et al. Impact of Timing of Concurrent Chemoradiation for Newly Diagnosed Glioblastoma: A Critical Review of Current Evidence. Neurosurgery. 2015;62(1):160\u20135. 10.1227\/neu.0000000000000801.","journal-title":"Neurosurgery"},{"issue":"3","key":"ref14","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.gendis.2016.04.007","article-title":"Temozolomide resistance in glioblastoma multiforme","volume":"3","author":"Lee SY","year":"2016","unstructured":"Lee SY. Temozolomide resistance in glioblastoma multiforme. Genes Dis. 2016;3(3):198\u2013210. 10.1016\/j.gendis.2016.04.007.","journal-title":"Genes Dis"},{"issue":"11","key":"ref15","doi-asserted-by":"publisher","first-page":"27796","DOI":"10.3390\/ijms161126068","article-title":"Cellular and Functional Effects of Radiation-Induced Brain Injury: A Review","volume":"16","author":"Balentova S","year":"2015","unstructured":"Balentova S, Adamkov M, Molecular. Cellular and Functional Effects of Radiation-Induced Brain Injury: A Review. Int J Mol Sci. 2015;16(11):27796\u2013815. 10.3390\/ijms161126068.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"ref16","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1093\/brain\/awz275","article-title":"Induction of immunological tolerance to myelinogenic glial-restricted progenitor allografts","volume":"142","author":"Li S","year":"2019","unstructured":"Li S, Oh BC, Chu C, et al. Induction of immunological tolerance to myelinogenic glial-restricted progenitor allografts. Brain. 2019;142(11):3456\u201372. 10.1093\/brain\/awz275.","journal-title":"Brain"},{"issue":"2","key":"ref17","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.stem.2015.01.004","article-title":"Human embryonic stem cell-derived oligodendrocyte progenitors remyelinate the brain and rescue behavioral deficits following radiation","volume":"16","author":"Piao J","year":"2015","unstructured":"Piao J, Major T, Auyeung G, et al. Human embryonic stem cell-derived oligodendrocyte progenitors remyelinate the brain and rescue behavioral deficits following radiation. Cell Stem Cell. 2015;16(2):198\u2013210. 10.1016\/j.stem.2015.01.004.","journal-title":"Cell Stem Cell"},{"issue":"3","key":"ref18","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/cvr\/cvn081","article-title":"Vascular repair by endothelial progenitor cells","volume":"78","author":"Zampetaki A","year":"2008","unstructured":"Zampetaki A, Kirton JP, Xu Q. Vascular repair by endothelial progenitor cells. Cardiovasc Res. 2008;78(3):413\u201321. 10.1093\/cvr\/cvn081.","journal-title":"Cardiovasc Res"},{"issue":"15","key":"ref19","doi-asserted-by":"publisher","first-page":"8286","DOI":"10.3390\/ijms23158286","article-title":"Microglia as Therapeutic Target for Radiation-Induced Brain Injury","volume":"23","author":"Liu Q","year":"2022","unstructured":"Liu Q, Huang Y, Duan M, Yang Q, Ren B, Tang F. Microglia as Therapeutic Target for Radiation-Induced Brain Injury. Int J Mol Sci. 2022;23(15):8286. 10.3390\/ijms23158286.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"ref20","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1080\/09553002.2022.2055804","article-title":"Radiation-induced neuropathological changes in the oligodendrocyte lineage with relevant clinical manifestations and therapeutic strategies","volume":"98","author":"Lee RX","year":"2022","unstructured":"Lee RX, Tang FR. Radiation-induced neuropathological changes in the oligodendrocyte lineage with relevant clinical manifestations and therapeutic strategies. Int J Radiat Biol. 2022;98(10):1519\u201331. 10.1080\/09553002.2022.2055804.","journal-title":"Int J Radiat Biol"},{"issue":"11","key":"ref21","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1002\/glia.23636","article-title":"Transcriptional control of myelination and remyelination","volume":"67","author":"Sock E","year":"2019","unstructured":"Sock E, Wegner M. Transcriptional control of myelination and remyelination. Glia. 2019;67(11):2153\u201365. 10.1002\/glia.23636.","journal-title":"Glia"},{"issue":"4","key":"ref22","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/jnc.15728","article-title":"Oligodendrocyte lineage cells: advances in development, disease, and heterogeneity","volume":"164","author":"Wang JQ","year":"2022","unstructured":"Wang JQ, Gao MY, Gao R, Zhao KH, Zhang Y, Li X. Oligodendrocyte lineage cells: advances in development, disease, and heterogeneity. J Neurochem. 2022;164(4):468\u201380. 10.1111\/jnc.15728.","journal-title":"J Neurochem"},{"issue":"1","key":"ref23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.expneurol.2005.11.023","article-title":"Oligodendrocyte progenitor cell (OPC) transplantation is unlikely to offer a means of preventing X-irradiation induced damage in the CNS","volume":"198","author":"Chari DM","year":"2006","unstructured":"Chari DM, Gilson JM, Franklin RJM, Blakemore WF. Oligodendrocyte progenitor cell (OPC) transplantation is unlikely to offer a means of preventing X-irradiation induced damage in the CNS. Exp Neurol. 2006;198(1):145\u201353. 10.1016\/j.expneurol.2005.11.023.","journal-title":"Exp Neurol"},{"issue":"6619","key":"ref24","doi-asserted-by":"publisher","first-page":"eadc9020","DOI":"10.1126\/science.adc9020","article-title":"Molecular basis of astrocyte diversity and morphology across the CNS in health and disease","volume":"378","author":"Endo F","year":"2022","unstructured":"Endo F, Kasai A, Soto JS, et al. Molecular basis of astrocyte diversity and morphology across the CNS in health and disease. Science. 2022;378(6619):eadc9020. 10.1126\/science.adc9020.","journal-title":"Science"},{"issue":"3","key":"ref25","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1667\/rr2773.1","article-title":"Radiation-induced vascular damage in tumors: implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS)","volume":"177","author":"Park HJ","year":"2012","unstructured":"Park HJ, Griffin RJ, Hui S, Levitt SH, Song CW. Radiation-induced vascular damage in tumors: implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS). Radiat Res. 2012;177(3):311\u201327. 10.1667\/rr2773.1.","journal-title":"Radiat Res"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fonc.2012.00073","article-title":"Radiation-induced brain injury: A review","volume":"2","author":"Greene-Schloesser D","year":"2012","unstructured":"Greene-Schloesser D, Robbins ME, Peiffer AM, Shaw EG, Wheeler KT, Chan MD. Radiation-induced brain injury: A review. Front Oncol. 2012;2:73. 10.3389\/fonc.2012.00073.","journal-title":"Front Oncol"},{"issue":"5","key":"ref27","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/j.ijrobp.2010.12.032","article-title":"Irradiation alters MMP-2\/TIMP-2 system and collagen type IV degradation in brain","volume":"82","author":"Lee WH","year":"2012","unstructured":"Lee WH, Warrington JP, Sonntag WE, Lee YW. Irradiation alters MMP-2\/TIMP-2 system and collagen type IV degradation in brain. Int J Radiat Oncol Biol Phys. 2012;82(5):1559\u201366. 10.1016\/j.ijrobp.2010.12.032.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"13","key":"ref28","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.3390\/cancers14133273","article-title":"HIF-1\u03b1 Inhibition Improves Anti-Tumor Immunity and Promotes the Efficacy of Stereotactic Ablative Radiotherapy (SABR)","volume":"14","author":"Song CW","year":"2022","unstructured":"Song CW, Kim H, Cho H, et al. HIF-1\u03b1 Inhibition Improves Anti-Tumor Immunity and Promotes the Efficacy of Stereotactic Ablative Radiotherapy (SABR). Cancers (Basel). 2022;14(13):3273. 10.3390\/cancers14133273.","journal-title":"Cancers (Basel)"},{"issue":"6","key":"ref29","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nrc2397","article-title":"Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response","volume":"8","author":"Dewhirst MW","year":"2008","unstructured":"Dewhirst MW, Cao Y, Moeller B. Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat Rev Cancer. 2008;8(6):425\u201337. 10.1038\/nrc2397.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"ref30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.0953-816X.2004.03451.x","article-title":"Developmental up-regulation of MnSOD in rat oligodendrocytes confers protection against oxidative injury","volume":"20","author":"Baud O","year":"2004","unstructured":"Baud O, Haynes RF, Wang H, et al. Developmental up-regulation of MnSOD in rat oligodendrocytes confers protection against oxidative injury. Eur J Neurosci. 2004;20(1):29\u201340. 10.1111\/j.0953-816X.2004.03451.x.","journal-title":"Eur J Neurosci"},{"issue":"16","key":"ref31","doi-asserted-by":"publisher","first-page":"6241","DOI":"10.1523\/jneurosci.18-16-06241.1998","article-title":"Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion","volume":"18","author":"Back SA","year":"1998","unstructured":"Back SA, Gan X, Li Y, Rosenberg PA, Volpe JJ. Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. J Neurosci. 1998;18(16):6241\u201353. 10.1523\/jneurosci.18-16-06241.1998.","journal-title":"J Neurosci"},{"issue":"2","key":"ref32","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.cell.2014.04.052","article-title":"Oligodendrocyte-encoded HIF function couples postnatal myelination and white matter angiogenesis","volume":"158","author":"Yuen TJ","year":"2014","unstructured":"Yuen TJ, Silbereis JC, Griveau A, et al. Oligodendrocyte-encoded HIF function couples postnatal myelination and white matter angiogenesis. Cell. 2014;158(2):383\u201396. 10.1016\/j.cell.2014.04.052.","journal-title":"Cell"},{"issue":"3","key":"ref33","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1182\/blood.2020007535","article-title":"Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial","volume":"137","author":"Fuchs EJ","year":"2021","unstructured":"Fuchs EJ, O'Donnell PV, Eapen M, et al. Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial. Blood. 2021;137(3):420\u20138. 10.1182\/blood.2020007535.","journal-title":"Blood"},{"issue":"22","key":"ref34","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1001\/jama.2009.813","article-title":"Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials","volume":"301","author":"Koreth J","year":"2009","unstructured":"Koreth J, Schlenk R, Kopecky KJ, et al. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials. JAMA. 2009;301(22):2349\u201361. 10.1001\/jama.2009.813.","journal-title":"JAMA"},{"issue":"6","key":"ref35","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.3390\/antiox11061050","article-title":"Transplantation of Human Glial Progenitors to Immunodeficient Neonatal Mice with Amyotrophic Lateral Sclerosis (SOD1\/rag2)","volume":"11","author":"Stanaszek L","year":"2022","unstructured":"Stanaszek L, Rogujski P, Drela K, et al. Transplantation of Human Glial Progenitors to Immunodeficient Neonatal Mice with Amyotrophic Lateral Sclerosis (SOD1\/rag2). Antioxid (Basel). 2022;11(6):1050. 10.3390\/antiox11061050.","journal-title":"Antioxid (Basel)"},{"issue":"9","key":"ref36","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1038\/s41591-022-01956-3","article-title":"Transplantation of human neural progenitor cells secreting GDNF into the spinal cord of patients with ALS: a phase 1\/2a trial","volume":"28","author":"Baloh RH","year":"2022","unstructured":"Baloh RH, Johnson JP, Avalos P, et al. Transplantation of human neural progenitor cells secreting GDNF into the spinal cord of patients with ALS: a phase 1\/2a trial. Nat Med. 2022;28(9):1813\u201322. 10.1038\/s41591-022-01956-3.","journal-title":"Nat Med"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3500563\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3500563\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T08:29:35Z","timestamp":1699777775000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-3500563\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,1]]},"references-count":36,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-3500563\/v1","relation":{},"subject":[],"published":{"date-parts":[[2023,11,1]]},"subtype":"preprint"}}